Fibromyalgia is the most common, chronic widespread pain condition in the United States and is thought to result from neurological changes in how patients perceive pain. Fibromyalgia is usually accompanied by poor sleep, stiffness and fatigue... Pfizer's Press Release -
Blog Archive
-
▼
2008
(56)
-
▼
May
(10)
- Sepracor : LUNESTA Study of Patients with Insomnia...
- Lundbeck : Circadin launch rollout starts with the...
- SOMAXON PHARMACEUTICALS : CLINICAL DATA ON PRODUCT...
- Medison Pharma : Provigil is approved for Idiopath...
- Eurand : Launch of OTC Unisom SleepMelts by Chattem
- Pfizer : Lyrica Reduced Pain of Fibromyalgia in Pa...
- Sanofi-aventis : Positive results from GEMS, the t...
- XenoPort and GlaxoSmithKline : XP13512/GSK1838262...
- Transcept Pharmaceuticals : Study of Intermezzo by...
- SleepQuest : Medicare Approves In Home Sleep Apnea...
-
▼
May
(10)
Tuesday, May 13, 2008
Pfizer : Lyrica Reduced Pain of Fibromyalgia in Patients Regardless of Symptoms of Anxiety or Depression
April 16, 2008 - -Pfizer’s Lyrica reduced pain of fibromyalgia in patients regardless of whether they experienced symptoms of anxiety or depression at the beginning of the study, according to a pooled analysis presented today at the American Academy of Neurology annual meeting. The analysis, which looked at data pooled from previous clinical trials, also showed that patients’ self-reported improvements were more closely associated with improvements in pain and sleep than with improvements in fatigue or symptoms of anxiety or depression.